MENU
HRMY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Harmony Biosciences Holdings (HRMY) Ownership - Who owns Harmony Biosciences Holdings?
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs... Show more
Profile
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.12B
P/E Ratio
11.90
Total Cash
565.27M
Projected Growth
N/A
Total Debt
172.1M
Revenue
772.53M
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash/Share
9.83
Total Debt/Equity
N/A
Revenue/Share
13.25 USD as % of share price
Fundamentals
HRMY
Capitalization
2.12B
P/E Ratio
11.90
Risk (Beta)
1.31
Dividend Yield
N/A
Total Cash
565M
Total Cash/Share
9.83
Total Debt
172M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
13.25%
Revenue
773M
ROE
N/A
Book Value
773M
P/B Ratio
2.74
Cash Flow
N/A
Earnings
3.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
3.84
Current Revenue Per Employee
748093.30
Dividends Per Share - Security
N/A
EBITDA
265M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.97
Revenue To Assets
18.40
Shares Held By Institutions
2.77B
Shares Outstanding - Current
57.5M
Total Liabilities
335M
Total Volume MTD
N/A
Value
N/A
Gain YTD
7.207
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HRMY showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
630 West Germantown Pike
Phone
+1 484 539-9800
Employees
246
Web
https://www.harmonybiosciences.com